SP1 and Miyoshi myopathy: At the molecular level, our results demonstrate that G-1 treatment affected the previously characterized miR-29b-Sp1 transcriptional feedback loop [38], as suggested by the induction of miR-29b in MM cell lines, and the concomitant down-regulation of Sp1.